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AbstrACt
Objective To determine whether there is an association 
between dietary patterns/indices and foods from the main 
food groups (highest vs lowest intakes) prior to or after 
cancer diagnosis and mortality and cancer recurrence in 
cancer survivors.
Participants Survivors of common cancers with a 10-
year survival rate of ≥50%: bladder, bowel, breast, cervical, 
kidney, laryngeal, prostate, testicular, uterine cancer, 
malignant melanoma and (non-)Hodgkin’s lymphoma.
Outcome measures Mortality (overall, cancer-specific, 
from other causes) and cancer recurrence.
Information sources PubMed, Embase and the Cochrane 
Library were searched from inception to April 2017. 
Additional studies were identified by searching reference 
lists. Two authors independently screened titles and 
abstracts, assessed study quality and extracted the data.
results A total of 38 studies were included. The risk of 
bias was rated low for the included randomised controlled 
trials (RCTs) and moderate for the cohort studies. The 
quality of evidence was assessed with the Grading 
of Recommendations, Assessment, Development and 
Evaluations (GRADE) approach and was rated moderate 
(RCTs), and (very)low (cohort studies). Reducing the 
amount of fat after diagnosis appears to decrease the risk 
of breast cancer recurrence. Adherence to a high-quality 
diet and prudent diet after diagnosis appears to decrease 
the risk of death from other causes (and overall mortality 
for high-quality diet) in breast cancer survivors. Adherence 
to a Western diet, before and after diagnosis, appears to 
increase the risk of overall mortality and death from other 
causes among breast cancer survivors. Evidence from 
studies among other cancer survivors was too limited or 
could not be identified.
Conclusion For many cancer survivors, there is little 
evidence to date to indicate that particular dietary 
behaviours influence outcomes with regard to recurrence 
and mortality. Notwithstanding, limited evidence suggests 
that a low-fat diet, a high-quality diet and a prudent diet 
are beneficial for breast cancer survivors, while a Western 
diet is detrimental for breast cancer survivors.
IntrOduCtIOn
As cancer survival rates continue to improve, 
there is an increased need to identify 
modifiable lifestyle factors among cancer 
survivors in order to improve long-term 
health.
Adherence to a diet rich in fruit and vege-
tables could decrease the risk of several types 
of cancer and increase overall life expec-
tancy.1 2 The suggestion that epigenetic aber-
rations occurring in cancer could be altered 
by nutrients makes it plausible that dietary 
changes after successful cancer treatment 
could improve prognosis.3 4
Although cancer survivors are responsive 
to health promotion,5 6 a recent study has 
indicated that survivors had poorer diets than 
individuals without cancer.7 One possible 
explanation could be the difficulty for cancer 
survivors in adopting a healthier diet without 
clear evidence that it will improve their 
survival.8 While guidelines have been well 
documented for the prevention of cancer, 
many uncertainties remain for nutrition 
after cancer treatment.9 A systematic review, 
as part of the Continuous Update Project 
of the World Cancer Research Fund Inter-
national, was published on diet, nutrition, 
physical activity and survival in breast cancer 
survivors.10 The independent panel of scien-
tists concluded that the evidence to date was 
strengths and limitations of this study
 ► Dietary patterns/indices and whole foods reflect the 
complexity of dietary intake and capture synergistic 
relationships between various dietary constituents.
 ► Most studies investigating dietary patterns/
indices and foods before diagnosis do not consider 
potential modifications in dietary intake after cancer 
diagnosis.
 ► Cohort studies provide weaker empirical evidence 
than randomised controlled trials for examining 
relationships between dietary exposure and 
mortality and cancer recurrence.
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not strong enough to make specific recommendations 
for breast cancer survivors. A recent meta-analysis inves-
tigating the role of diet on overall mortality and recur-
rence among cancer survivors concluded that adherence 
to a Western diet is positively associated with overall 
mortality, and a high-quality diet/healthy dietary pattern 
is inversely associated with overall mortality among all 
cancer survivors.11
In the setting of survivors of cancers with a 10-year 
survival rate ≥50%, this systematic review provides a struc-
tured overview of randomised controlled trials (RCTs) 
and cohort studies addressing the relationship between 
adherence to dietary patterns/indices and intake of 
foods from the main food groups, prior to or after cancer 
diagnosis, and health outcomes including cancer recur-
rence, cancer-specific mortality, overall mortality and 
death from other causes than cancer. Given that these 
survivors have the potential for long-term survival, they 
may be most likely to benefit from dietary changes to 
prevent or delay cancer recurrence and improve survival. 
Notwithstanding, many of these survivors will die from 
other causes such as cardiovascular disease—even if the 
dietary exposures identified will not help the investigated 
outcomes, it could be desirable to follow a diet that could 
help reduce other conditions.
MethOds
search strategy
From inception up to April 2017, PubMed, Embase and the 
Cochrane Library were searched to find English-language 
articles of original and published randomised trials and 
observational studies to answer the following research ques-
tion: does adherence to/intake of dietary patterns/indices 
and foods (highest vs lowest adherence/intake) prior to 
or after cancer diagnosis increase or decrease the risk of 
mortality and cancer recurrence among cancer survivors of 
common cancers with a 10-year survival rate of ≥50%? This 
research question was developed using the PICO frame-
work;P: patient, population, or problem; I: intervention, 
prognostic factor, or exposure; C: comparison or interven-
tion; O: outcome (supporting data review protocol online 
supplementary file S1). Search strategies included search 
terms related to dietary patterns, dietary indices, diet quality, 
foods from the main food groups and outcomes of interest, 
including overall mortality, cancer-specific mortality, death 
from other causes and recurrence of cancer. Additionally, 
studies were identified by searching reference lists of rele-
vant studies, literature reviews and meta-analyses. After the 
search was completed, articles were screened and selected 
independently based on the title and abstract by two of the 
authors (SJ and FvO). The data extraction was performed 
independently by the same authors (SJ and FvO) and any 
disagreements about study inclusion were resolved through 
consensus or a third party.
Inclusion and exclusion criteria
Eligibility criteria included adult survivors of cancer (no 
sex or age restriction) who were defined as individuals 
who had been diagnosed with a primary cancer, received 
cancer therapy and were in remission or had recovered 
completely from cancer. Considered cancer types were 
the commonly occurring cancers in the Western world 
with a 10-year net survival of at least 50% (based on 
cancer diagnoses of men and women during 2010–2011 
in England and Wales).12 These include in decreasing 
order of net survival: testicular cancer (98%), malig-
nant melanoma (MM) (89%), prostate cancer (84%), 
Hodgkin’s lymphoma (HL) (80%), breast cancer (78%), 
uterine cancer (77%), non-Hodgkin’s lymphoma (NHL) 
(63%), cervical cancer (63%), laryngeal cancer (62%), 
bowel cancer (57% including both colon and rectal 
cancer), bladder cancer (50%) and kidney cancer (50%). 
In the statistical analyses, adjustments had to be made 
for at least age and disease stage at baseline and, where 
possible, for cancer treatment. Excluded papers did not 
state HRs or relative risks (RRs), nor 95% CIs; neither 
did they provide information on disease stage or tumour 
grade or therapy. Additionally, studies were excluded 
when outcomes were combined, such as mortality and 
cancer progression, mortality and diagnosed metastasis, 
or where prostate cancer recurrence was determined by a 
rising prostate specific antigen (PSA) level only.
dietary exposure
Dietary patterns/indices that were considered were 
assessed by index-based methods and data-driven 
approaches, such as principal component analysis (factor 
analysis) and cluster analysis.13 The following diet scores 
were considered: the Healthy Eating Index 2005 (HEI-
2005),14 15 the alternate Healthy Eating Index 2010 
(AHEI),16 the World Cancer Research Fund and the 
American Institute for Cancer Research (WCRF/AIRC) 
dietary guidelines adherence score17 and the American 
Cancer Society (ACS) diet-specific recommendations 
for cancer prevention,18 the recommended food score 
(RFS),19 the Diet Quality Index-Revised (DQIR),20 the 
Dietary Approaches to Stop Hypertension diet (DASH) 
diet,21 the Healthy Nordic Food Index (HNFI)22 
and the alternate Mediterranean diet (aMed)23 24; 
empirical patterns reviewed included a low-fat diet, a 
prudent/healthy diet and a Western/unhealthy diet. The 
HEI-2005 was developed by the US Department of Agricul-
ture and targets foods that could possibly reduce the risk 
of chronic diseases and include fruits, vegetables, fibre, 
soy, nuts, ratio white and red meat, alcohol, trans fat, satu-
rated fat ratio and multivitamin use.14 Five years later, the 
AHEI was introduced, which differs from the HEI-2005 by 
distinguishing quality within food groups and recognising 
health benefits of unsaturated oils.25 The RFS includes 
the foods fruits, vegetables, whole grains, dairy and 
protein foods low in fat. Diet diversity and moderation 
was addressed by the DQIR and included fruits, vegeta-
bles, cholesterol, total fat, saturated fat, iron, calcium and 
fat/sugar moderation. The aMed is based on the original 
Mediterranean diet score and includes fruits, vegetables, 
legumes, nuts, whole grains, red and processed meat, 
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moderate alcohol and the ratio of monounsaturated and 
saturated fat.26 27 In addition, whole foods of the main 
food groups (UK Eatwell Guide)28 were considered. The 
composition of the investigated groups was as follows: 
(1) fruit and vegetables including citrus fruits, stone 
fruits, soft fruits, fleshy fruits, vine fruits, flower vegeta-
bles, leafy vegetables, stem vegetables, fruit vegetables, 
mushrooms, bulbs and roots; (2) grain foods including 
potatoes, bread, rice, pasta and cereal; (3) protein foods 
including unprocessed meat, red meat, poultry, fish, 
eggs, tofu, nuts, seeds, pulses, legumes and beans; (4) 
dairy and alternative products including yoghurt, milk 
and cheese; and (5) oils and spreads including vegetable 
oils and spreads. Although processed (red) meats are not 
included in the main food groups recommended by the 
UK Eatwell Guide, lean red meats (rich in protein, iron, 
zinc, selenium and B vitamins) can be part of a healthy 
diet. Therefore, studies that made no distinction between 
(lean) red meats and processed meats in their estimates 
were still included in this systematic review. Information 
on intake of food was obtained before or after cancer 
diagnosis with food records, food frequency question-
naires (FFQ) (self-administered or via an interview) or 
24-hour recalls, and expressed in servings or (milli)grams 
per day/week/month. No restrictions were made for time 
of follow-up, and timing or frequency of dietary intake.
Mortality and cancer recurrence
Considered endpoints were overall mortality, cancer-spe-
cific mortality, death from other causes and cancer 
recurrence. The cause of death was confirmed via death 
certificates or the National Death Index in each of the 
studies. Cancer recurrence was defined as a new occur-
rence of cancer after a period of time during which the 
cancer could not be detected at the same or at a different 
site to the initial primary tumour. Cancer recurrence had 
to be confirmed by a biopsy, scan, medical record, cancer 
registry or treating physician.
Assessment risk of bias and level of quality
The Cochrane Collaboration risk of bias assessment tools 
were used for appraisal of RCTs29 and cohort studies.30 
For RCTs, the RoB V.2.0 tool (a revised tool for risk of bias 
in randomised trials) was used to evaluate the risk of bias. 
Cohort studies were appraised with an adjusted version of 
the ROBINS-I tool.29 30 Levels of quality were determined 
with the Grading of Recommendations, Assessment, 
Development and Evaluations (GRADE) approach31; 
evidence from RCTs or multiple double-upgraded obser-
vational studies were considered as high quality, down-
graded RCTs or upgraded observational studies were 
considered as moderate quality, double-downgraded 
RCTs or observational studies were considered as low 
quality, and triple-downgraded RCTs, downgraded obser-
vational studies or case series/case reports were consid-
ered as very low quality.31 Factors reducing the quality of 
the evidence include limitations in study design, incon-
sistency between study results, indirectness of evidence, 
imprecision and publication bias. Factors increasing the 
quality of the evidence include a large magnitude of 
effect, correction for all plausible confounding that could 
reduce the demonstrated effect or increase the effect if 
no effect was observed, and presence of a dose–response 
gradient. For observational studies, this could intent 
controlling for key knows risk factors and confounders. 
GRADE separates the process of assessing the quality of 
evidence from making recommendations. To determine 
whether evidence for an association between dietary 
patterns/indices or foods and mortality or cancer recur-
rence among cancer survivors was conclusive, the risk of 
bias and levels of quality were considered.
results
The search resulted in 2883 citations after removal of 
duplicates. After screening the titles and abstracts, 95 
full-text articles were assessed for eligibility—a total 
of 2 RCTs and 36 cohort studies were included in this 
systematic review. No studies could be identified for 
cervical, kidney, testicular, uterine cancer, HL or MM 
survivors. Dietary patterns/indices could be identified 
for bowel, breast, prostate cancer and NHL. Whole 
foods from the main food groups could be identified 
for bladder, bowel, breast, laryngeal, prostate cancer 
and NHL survivors.
The protocol used for this systematic review is available 
in the supporting data (online supplementary file S1). A 
detailed search strategy is provided in box and the search 
box literature search for the PubMed database 
addressing the relationship between diet and mortality 
among bladder cancer survivors
(“urinary bladder neoplasms”[Mesh] OR “urinary bladder neoplasm*” 
OR “bladder cancer*” OR “bladder tumor*” OR “bladder tumour*”) AND 
(“mortalit*” OR “mortality”[Mesh] OR “death”[Mesh] OR “recurrence*” 
OR “recurrence”[Mesh] OR “surviv*” OR “survival”[Mesh] OR 
“disease-free survival”[Mesh] OR “survival analysis”[Mesh] OR 
“survival rate”[Mesh]) OR “proportional hazards models”[Mesh] OR 
“kaplan-meier” OR “cox” OR “survivors”[Mesh]) AND (“diet*” OR 
“diet”[Mesh] OR “dietary pattern*” OR “diet, Mediterranean”[Mesh] 
OR “diet, vegetarian”[Mesh] OR “diet, Western”[Mesh] OR “energy 
intake”[Mesh] OR “caloric restriction”[Mesh] OR “low calorie diet” OR 
“low fat diet” OR “dietary fat*” OR “dietary carbohydrate*” OR “dietary 
fiber OR “dietary protein*” OR “nutrition*” OR “food*” OR “fruit”[Mesh] 
OR “fruit*” OR “citrus fruit*” OR “vegetables”[Mesh] OR “vegetable*” 
OR “brassica” OR “cruciferous vegetable*” OR “meat”[Mesh] OR “red 
meat”[Mesh] OR “meat*” OR “beef” OR “pork” OR “lamb” OR “poultry” 
OR “chicken” OR “turkey” OR “duck” OR “fish products”[Mesh] OR 
“fish” OR “shellfish” OR “seafood” OR “dairy” OR “milk” OR “ghee” 
OR “cheese” OR “egg*” OR “nut*” OR “edible grain”[Mesh] OR “whole 
grains”[Mesh] OR “potato*” OR “bread” OR “cereal*” OR “rice*”) NOT 
(“DNA-Binding Proteins”[Mesh] OR “Peptides”[Mesh] OR “Intercellular 
Signaling Peptides and Proteins”[Mesh] OR “Chromosomes, 
Human”[Mesh] OR “Immunohistochemistry”[Mesh] OR “In Situ 
Hybridization, Fluorescence”[Mesh]) AND (“humans”[MeSH Terms] 
AND English[lang]
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was adapted accordingly for the individual cancers and 
databases (online supplementary file S1). The review 
was written according to the Preferred Reporting Items 
for Systematic reviews and Meta-Analyses (PRISMA) 
guidelines.32 A summary of the number of studies for 
prediagnosis dietary patterns/indices (table 1) and post-
diagnosis dietary patterns/indices (table 2) and mortality 
and cancer recurrence is provided. Additionally, tables 
with the number of studies for prediagnosis food intake 
(table 3) and postdiagnosis food intake (table 4) and 
mortality and cancer recurrence are given. The study 
characteristics including the HRs/RRs with their corre-
sponding 95% CI are provided in the supporting data 
(online supplementary file S2).
Templates of the RoB 2.0 and ROBINS-I tools can be 
found in the supporting data (online supplementary file 
S1). Results for the assessment of the risk of bias for each 
individual RCT (RoB 2.0) and cohort study (ROBINS-I) 
Table 1 Number of studies investigating the association between prediagnosis dietary patterns/indices and mortality/cancer 
recurrence in different populations of cancer survivors
Cancer 
site/type
Diet quality indices Prudent/healthy diet Western diet/unhealthy diet
Studies (n) CR OM CSM DO Studies (n) CR OM CSM DO Studies (n) CR OM CSM DO
Bladder 0 – – – – 0 – – – – 0 – – – –
Bowel 2 – 2 1 – 1 – 1 1 – 1 – 2 2 –
Breast 1 – 1 1 1 2 1 4 4 4 2 1 4 4 4
Cervix 0 – – – – 0 – – – – 0 – – – –
HL 0 – – – – 0 – – – – 0 – – – –
Kidney 0 – – – – 0 – – – – 0 – – – –
Larynx 0 – – – – 0 – – – – 0 – – – –
MM 0 – – – – 0 – – – – 0 – – – –
NHL 0 – – – – 0 – – – – 0 – – – –
Prostate 0 – – – – 0 – – – – 0 – – – –
Testes 0 – – – – 0 – – – – 0 – – – –
Uterus 0 – – – – 0 – – – – 0 – – – –
The number of studies does not correspond with the number of outcomes as some studies investigate multiple outcomes and several dietary 
patterns in the same population.
CR, cancer recurrence; CSM, cancer-specific mortality; DO, death from other causes than cancer; HL, Hodgkin’s lymphoma; MM, 
malignant melanoma; NHL, non-Hodgkin’s lymphoma; OM, overall mortality.
Table 2 Number of studies investigating the association between postdiagnosis dietary patterns/indices and mortality/cancer 
recurrence in different populations of cancer survivors
Cancer 
site/type
Diet quality indices Prudent diet/healthy diet Western diet/unhealthy
Studies (n) CR OM CSM DO Studies (n) CR OM CSM DO Studies (n) CR OM CSM DO
Bladder 0 – – – – 0 – – – – 0 – – –
Bowel 2 – 5 3 – 2 1 2 1 – 2 1 2 1 –
Breast 7 1 11 9 8 2 1 2 2 2 2 1 2 2 2
Cervix 0 – – – – 0 – – – – 0 – – – –
HL 0 – – – – 0 – – – – 0 – – – –
Kidney 0 – – – – 0 – – – – 0 – – – –
Larynx 0 – – – – 0 – – – – 0 – – – –
MM 0 – – – – 0 – – – – 0 – – – –
NHL 0 – – – – 0 – – – – 0 – – – –
Prostate 1 – 1 1 – 1 – 1 1 – 1 – 1 1 –
Testes 0 – – – – 0 – – – – 0 – – – –
Uterus 0 – – – – 0 – – – – 0 – – – –
The number of studies does not correspond with the number of outcomes as some studies investigate multiple outcomes and several dietary 
patterns in the same population.
CR, cancer recurrence; CSM, cancer-specific mortality; DO, death from other causes than cancer; HL, Hodgkin’s lymphoma; MM, 
malignant melanoma; NHL, non-Hodgkin’s lymphoma; OM, overall mortality.
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will be provided on request. Briefly, the included RCTs 
investigating a low-fat diet and mortality among breast 
cancer survivors indicated a low risk of bias33; the included 
cohort studies all had a moderate risk of bias.34
An overview of the GRADE ratings with comments can 
be found in the supporting data (online supplementary 
file S3). As the risk of bias was rated ‘low’ and ‘moderate’, 
there was no reason to downgrade the quality of evidence 
on this matter. The quality level of the body of evidence 
of the studies was rated ‘very low’, ‘low’ and ‘moderate’ 
by two of the authors (SJ and FvO) when applying the 
grading system developed by the GRADE collabora-
tion.31 Briefly, the level of evidence for the association 
between a low-fat diet and bladder cancer recurrence and 
mortality was downgraded from ‘high’ to ‘moderate’ due 
to the presence of potential confounding factors in many 
studies. Evidence for associations between dietary factors 
and bladder cancer recurrence and mortality from cohort 
studies could not score higher than ‘low’ level of evidence 
and was downgraded to ‘very low’ if inconsistent, indirect 
or under suspicion of publication bias.
bladder cancer
A total of one cohort study could be identified for bladder 
cancer survivors regarding fruit and vegetable consump-
tion. The study of Tang et al investigated prediagnosis fruit 
and vegetable consumption with data from 239 male and 
female bladder cancer survivors from the Roswell Park 
Cancer Institute Tumor Registry.35 After an average of 
8-year follow-up, no associations were observed between 
overall mortality or bladder cancer-specific mortality 
when comparing survivors with the highest intakes of 
total fruit, total vegetables or other cruciferous vegetables 
(raw or cooked) with those in the lowest intake group. 
An association was, however, observed for broccoli intake 
(≥1 vs <1 serving per month) with overall mortality (broc-
coli raw HR=0.57; 95% CI 0.39 to 0.83, broccoli cooked 
HR=0.67; 95% CI 0.49 to 0.91) and bladder cancer-spe-
cific mortality (broccoli raw HR=0.43; 95% CI 0.25 to 
0.74). The intake of other raw and cooked vegetables 
including cabbage, cauliflower, Brussels sprouts, kale, 
turnip, collard or mustard greens was not related with 
mortality.35
In summary, no conclusive evidence for an association 
between vegetable and fruit intake and mortality among 
bladder cancer survivors could be provided as evidence 
for each exposure and outcome was based on the results 
of one study only.
bowel cancer
A total of 12 cohort studies could be identified for bowel 
cancer survivors. Three observational cohort studies could 
be identified investigating the role of a prediagnosis and 
postdiagnosis prudent diet on mortality in bowel cancer 
survivors. Results of the Cancer and Leukemia Group B 
study indicated no associations between a prudent diet 
after cancer diagnosis and decreased mortality.36 However, 
there was a higher overall mortality among these survivors 
with the highest postdiagnosis intakes of a Western diet in 
comparison with those in the lowest category (HR=2.32; 
95% CI 1.36 to 3.96).36 When comparing participants in 
the Familial Bowel Cancer Registry with the highest and 
lowest intakes of a prudent diet before cancer diagnosis, 
no associations were found with mortality.37 Besides a 
prudent diet, two other dietary patterns comparable 
with a Western diet were identified in this study: a high 
processed meat pattern and a high sugar pattern diet. 
No associations were reported for the pattern high in 
sugar and mortality when comparing the highest to the 
lowest intake group, whereas a high processed meat 
pattern was specifically related to increased colon cancer 
mortality (HR=2.13; 95% CI 1.03 to 4.43). This relation-
ship between a processed meat pattern and bowel cancer 
survival was modified by sex.37 In the Nurses' Health Study 
(NHS), no associations were observed between adher-
ence to the AHEI, DASH or aMed score, a prudent diet 
or a Western diet after diagnosis and mortality in these 
bowel cancer survivors.23 It should be noted, however, 
that even though there was ‘no statistically significant’ 
result for the role of a postdiagnosis Western diet in this 
study, the HR was >1 (HR=1.31; 95% CI 0.89 to 1.97) as 
observed in the earlier described study of Meyerhardt et 
al (HR=2.32; 95% CI 1.36 to 3.96).36 Adherence to the 
HEI diet score was investigated in a large study including 
5727 male and female survivors in the USA and indicated 
no association between prediagnosis adherence to the 
HEI-2005 score with overall mortality or cancer-specific 
mortality.38 Recently, a German study examined adher-
ence to the Modified Mediterranean Diet Score (MMDS) 
and the HNFI and found that postdiagnosis adherence to 
this MMDS was associated with a decreased risk of overall 
mortality among bowel cancer survivors (HR=0.48; 
95% CI 0.32 to 0.74).39 In the European Prospective 
Investigation into Cancer and Nutrition cohort, data 
from participants of 10 European countries were anal-
ysed on adherence to WCRF/AICR diet scores and 
intake of total dairy, milk, yoghurt, cheese, red meat and 
poultry.39–42 Prediagnosis adherence to this high-quality 
diet score indicated a decreased risk of overall mortality 
among bowel cancer survivors (HR=0.79; 95% CI 0.65 to 
0.98).41 No evidence of an association with mortality was 
observed for foods from the main food groups, including 
fruits, vegetables, dairy or protein foods among these 
bowel cancer survivors.42 The study by Yang et al indi-
cated a protective association with milk consumption 
and overall mortality after a diagnosis of bowel cancer 
(RR=0.72; 95% CI 0.55 to 0.94).43 Additionally, no associa-
tion could be found for total dairy intake and mortality in 
this study.43 Whole gains, another food group investigated 
in bowel cancer survivors, were not associated with overall 
mortality among 1119 Danish, Swedish and Norwegian 
bowel cancer survivors in the HELGA cohort.44 Carr et al 
reported that red and processed meat consumption was 
not associated with a poorer survival among stage I–III 
bowel cancer survivors in a follow-up study of the Darm-
krebs: Chancen der Verhutung durch Screening study.45 
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However, it should be noted that the authors investigated 
red and processed meat combined and they suggest that 
major changes in the consumption of red meat measured 
at 5-year follow-up could have influenced survival.45 
The study of McCullough et al indicated an association 
with mortality when comparing highest versus lowest 
prediagnosis and postdiagnosis red and processed meat 
consumption for overall mortality (RR=1.29; 95% CI 1.05 
to 1.59) and death from other causes than bowel cancer 
(RR=1.39; 95% CI 1.00 to 1.92).46 It should be noted 
that the authors combined the consumption of red and 
processed meat in these estimates, and that there were no 
associations found for ‘fresh’ meats and mortality.46
In summary, no conclusive evidence for an association 
between adherence to a high-quality diet, a prudent diet, 
a Western diet and the consumption of fruits, vegetables, 
meats or dairy and mortality in bowel cancer survivors 
could be provided as evidence for each exposure and 
outcome was based on the results of one study only or on 
inconsistent results.
breast cancer
A total of 2 RCTs and 16 cohort studies could be iden-
tified for breast cancer survivors. Two dietary inter-
vention trials among breast cancer survivors met the 
inclusion criteria.47 48 The study of Chlebowski et al aimed 
to reduce postdiagnosis dietary fat intake to almost 
one-sixth of total energy intake while maintaining nutri-
tional adequacy in women participating in the Women’s 
Intervention Nutrition Study (trial registration number 
NCT00002564).47 Breast cancer survivors in the inter-
vention group were informed extensively on maintaining 
weight based on energy intake, while minimum dietary 
advice on nutrient intake was provided to breast cancer 
survivors in the control group. Women in the interven-
tion group had a lower dietary fat intake compared with 
those in the control group, whereas no differences could 
be observed for a lower energy or higher dietary fibre 
intake. According to the authors of this study, there was 
no association with overall mortality between women 
adhering to a low-fat diet and women given minimum 
dietary advice (HR=0.89; 95% CI 0.65 to 1.21). However, 
for relapse events (including local, regional, distant or 
ipsilateral breast cancer recurrence or new contralateral 
breast cancer) the HR of an event in the intervention 
group compared with the control group was HR=0.76; 
95% CI 0.60 to 0.98. This could indicate that a lifestyle 
intervention reducing dietary fat intake could improve 
relapse-free survival of breast cancer survivors.47 In the 
Women’s Healthy Eating and Living study (trial registra-
tion number NCT00003787), breast cancer survivors in 
the intervention group received telephone counselling 
with additional cooking classes and brochures to support 
adherence to a postdiagnosis diet high in fruit (three serv-
ings/day), high in vegetables (five servings/day and 16 oz 
of vegetable juice), high in fibre (30 g/day) and low in fat 
(15%–20% of energy intake from fat).48 In the control 
group, breast cancer survivors received written advice 
to eat at least five portions of fruit and vegetables each 
day (five-a-day advice). Differences between the former 
and latter groups in mean consumption of vegetables 
(+65%), fruit (+25%), fibre (+30%) and energy from fat 
(−13%) were observed at 4 years. The authors of this trial 
reported that no associations were observed for overall 
survival when comparing women in the intervention 
group with those in the control group (HR=0.91; 95% CI 
0.72 to 1.15).48 Although the results for overall mortality 
in the trials were statistically non-significant, the HRs of 
both studies were <1 (HR=0.89; 95% CI 0.65 to 1.2147 and 
HR=0.91; 95% CI 0.72 to 1.1548).
Postdiagnosis dietary indices were examined in the 
Health, Eating, Activity, and Lifestyle (HEAL) study,49 
Women’s Health Initiative’s Dietary Modification 
Trial and Observational Study (WHI),50 NHS24 51 and 
Cancer Prevention Study II Nutrition Cohort (CPS-II).52 
McCullough et al demonstrated that prediagnosis and 
postdiagnosis adherence to the ACS diet among breast 
cancer survivors in the CPS-II cohort was not association 
with breast cancer-specific mortality.52 It should be noted, 
however, that an inverse association was observed for the 
continuous postdiagnosis diet scores and other causes of 
death (RR=0.88; 95% CI 0.79 to 0.99).52 While no associa-
tions were found between prediagnosis and postdiagnosis 
fruit and vegetable intake and the intake of whole grains, 
detrimental associations were found with postdiagnosis 
red and processed meat consumption and overall mortality 
and death from other causes (respectively RR=0.64; 
95% CI 0.49 to 0.84 and RR=0.57; 95% CI 0.39 to 0.82).52 
In the NHS, postdiagnosis dietary DQIR, RFS, aMed, 
AHEI and DASH scores were not associated with overall 
mortality or breast cancer-specific mortality.24 51 Closer 
adherence to DASH and AHEI was, however, related to a 
lower risk of death from other causes than breast cancer 
(respectively RR=0.72; 95% CI 0.53 to 0.99 and RR=0.57; 
95% CI 0.42 to 0.77).51 George et al examined postdiag-
nosis adherence to the HEI-2005 scores and concluded 
that there was an association with a decreased risk of 
mortality (overall mortality HR=0.40; 95% CI 0.17 to 0.94 
and breast cancer-specific mortality HR=0.12; 95% CI 0.02 
to 0.99).49 In the WHI cohort, results of postdiagnosis 
adherence to the HEI-2005 scores indicated that women 
who consumed better quality diets had a 26% lower risk 
of overall mortality (HR=0.74; 95% CI 0.55 to 0.99) and a 
42% lower risk of death from non-breast cancer-related 
death (HR=0.58; 95% CI 0.38 to 0.87).50 Even though 
the result for breast cancer-specific mortality and adher-
ence to the HEI-2005 score in this study was statistically 
non-significant (HR=0.91; 95% CI 0.60 to 1.40), the HR is 
<1, as observed for women in the HEAL study regarding 
cancer-specific mortality.49 Results of the NHS indicated 
that a postdiagnosis prudent diet was not associated with 
overall or breast cancer-specific mortality while death 
from other causes was associated with a prudent diet after 
diagnosis when comparing breast cancer survivors of the 
highest and lowest intake group (HR=0.54; 95% CI 0.31 
to 0.95)53—adherence to a prudent diet before diagnosis 
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was not associated with mortality among breast cancer 
survivors in the NHS.53 Both prediagnosis and postdi-
agnosis adherence to a Western diet was associated with 
death from other causes (respectively RR=1.95; 95% CI 
1.06 to 3.60 and RR=2.31; 95% CI 1.23 to 4.32).53 The 
study of Kwan et al concludes no associations between 
adherence to a prediagnosis or postdiagnosis Western 
diet and overall mortality, breast cancer-specific mortality 
or cancer recurrence.54 The HR for a Western diet and 
death from other causes was, however, >1 (HR=2.15; 
95% CI 0.97 to 4.77),54 and therefore in agreement with 
the HR for a Western diet and death from other causes 
observed in the study of Kroenke et al (RR=2.09; 95% CI 
1.30 to 3.36).53 In the Life After Cancer Epidemiology 
(LACE) study, postdiagnosis adherence to a prudent 
diet in women with early-stage breast cancer resulted in 
a decreased risk of death from other causes (HR=0.35; 
95% CI 0.17 to 0.73) and overall mortality (HR=0.57; 
95% CI 0.36 to 0.90).54 The study of Vrieling et al inves-
tigated associations between a ‘healthy’ and ‘unhealthy’ 
prediagnosis dietary pattern and mortality in German 
breast cancer survivors in the Mammary carcinoma Risk 
factor Investigation (MARIE) study.55 The characteristics 
of the defined healthy diet are comparable with a prudent 
diet; nevertheless, no associations between the highest 
and lowest intake of this defined ‘healthy’ diet before 
cancer diagnosis and mortality in breast cancer survivors 
were observed. However, the results did indicate that a 
higher intake of an ‘unhealthy’ diet could increase the 
risk of death from other causes (HR=3.69; 95% CI 1.66 to 
8.17) among breast cancer survivors compared with those 
with the lowest intake of this diet.55
The majority of studies investigating prediagnosis or 
postdiagnosis fruit and vegetable intake indicated no 
association with mortality in breast cancer survivors. 
However, one study found that, when comparing post-
menopausal breast cancer survivors in the highest tertile 
to the lowest tertile group, prediagnosis total vegetable 
intake improved overall survival (HR=0.57; 95% CI 0.35 
to 0.94)—no association was found for total fruit intake 
and mortality in this cohort of breast cancer survivors.56 
In addition, Dal Maso et al found an association with total 
fruit and vegetable consumption and overall mortality 
(HR=1.27; 95% CI 1.00 to 1.61) when comparing survivors 
of the lowest intake group to the highest intake group.57 
Results from the After Breast Cancer Pooling Project, 
combining data from four cohort studies, indicated no 
association between postdiagnosis intakes of cruciferous 
vegetables and survival among 11 390 breast cancer survi-
vors.58 Holmes et al reported an association between the 
highest postdiagnosis poultry consumption and mortality 
in women once diagnosed with breast cancer (HR=0.70; 
95% CI 0.50 to 0.97).59 No associations were found for 
fish or red meat consumption and mortality in this popu-
lation. Additionally, a high dairy intake before diagnosis 
among female registered nurses who participated in the 
NHS was related to overall survival (HR=0.72; 95% CI 0.52 
to 1.00).59 Kroenke et al found that postdiagnosis dairy 
intake among women diagnosed with early-stage inva-
sive breast cancer in the LACE study was associated with 
an increased overall mortality (HR=1.39; 95% CI 1.02 to 
1.90).60 More specifically, high-fat dairy was related to 
overall mortality and breast cancer-specific mortality in 
these women (respectively HR=1.64; 95% CI 1.24 to 2.17 
and HR=1.49; 95% CI 1.00 to 2.24) while low-fat dairy was 
not.60 Beasley et al examined both meat and dairy intake 
after diagnosis and found no association with survival in 
the Collaborative Woman’s Longevity Study.61 Prediag-
nosis intakes of neither bread, sunflower/pumpkin seeds 
nor sesame/flaxseeds reduced the risk of mortality in the 
MARIE study.62 Finally, postdiagnosis butter/margarine/
lard consumption did increase the risk of breast cancer 
recurrence in a follow-up study among 472 breast cancer 
survivors enrolled from the Memorial Sloan-Kettering 
Cancer Centre (RR=1.30; 95% CI 1.03 to 1.64).63
In summary, no conclusive evidence could be provided 
for an association between most foods of the main food 
groups, including fruits, vegetables, meat or dairy, and 
cancer recurrence or mortality—evidence for each 
exposure and outcome was based on the results of one 
study only or on inconsistent results. However, limited 
evidence appears to indicate that the reduction of dietary 
fat after breast cancer diagnosis could increase relapse-
free survival among breast cancer survivors, adherence 
to the HEI-2005 score after diagnosis is associated with 
decreased overall mortality, adherence to the AHEI diet 
after diagnosis is associated with decreased death from 
other causes and that adherence to a prudent diet after 
diagnosis is associated with decreased death from other 
causes among breast cancer survivors. Adherence to a 
prediagnosis Western diet is associated with death from 
other causes while postdiagnosis adherence to a Western 
diet is associated with an increased risk of overall mortality 
in breast cancer survivors.
laryngeal cancer
One cohort study could be identified for the association 
between several foods from the main food groups and 
mortality among laryngeal cancer survivors.64 Crosignani 
et al examined dietary habits and survival in of 215 Italian 
male laryngeal cancer survivors on prediagnosis dietary 
habits and survival. The consumption of total vegetables 
(HR=0.57; 95% CI 0.35 to 0.94), beef/veal (HR=0.50; 
95% CI 0.30 to 0.83) and bread (HR=0.54; 95% CI 0.32 to 
0.90) were all associated with a decreased risk of overall 
mortality when comparing the highest versus the lowest 
intake group. No associations were found for poultry, 
fish, eggs, milk, cheese, pasta, potatoes, citrus fruits, other 
fruits, butter or olive oil. The authors speculate that the 
association between the highest beef/veal intakes and 
mortality could tentatively be interpreted as an indicator 
of a good nutritional status of those participants.64
In summary, no conclusive evidence for an association 
between fruits, vegetables, protein foods, grain foods, 
dairy or oils and spreads, and mortality among laryngeal 
cancer survivors could be provided, as evidence for each 
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exposure and outcome was based on the results of one 
study only.
non-hodgkin’s lymphoma
A total of two cohort studies could be identified for NHL 
survivors regarding the intake of food items. One study 
indicated that prediagnosis intakes of total fruit and vege-
tables and vegetables only (highest vs lowest intake) were 
associated with decreased overall mortality (respectively 
HR=0.68; 95% CI 0.49 to 0.95 and HR=0.58; 95% CI 0.38 
to 0.89) among female NHL survivors.65 Additionally, 
the highest intakes of citrus fruits and green leafy vege-
tables compared with the lowest intakes were related to 
overall mortality among survivors with NHL (respectively 
HR=0.73; 95% CI 0.54 to 0.99 and HR=0.71; 95% CI 0.51 to 
0.98). No associations were observed for total fruit intake, 
yellow vegetables, red vegetables or bean vegetables and 
mortality while subanalysis investigating fruit and vegeta-
bles separately for each NHL subtypes did; consumption 
of citrus fruits improved survival in diffuse large B-cell 
lymphoma survivors (overall mortality HR=0.40; 95% CI 
0.22 to 0.72, cancer-specific mortality HR=0.36; 95% CI 
0.16 to 0.80), and the highest consumption of green 
leafy vegetables favoured overall mortality in follicular 
lymphoma survivors (HR=0.27; 95% CI 0.10 to 0.76).65 
Although Leo et al found no association between predi-
agnosis intakes of fruit, vegetables, meat, fish or legumes, 
and mortality in 2339 NHL survivors,66 dairy intake did 
appear to be associated with a higher overall mortality 
(HR=1.14; 95% CI 1.00 to 1.31), yet not with NHL-specific 
mortality (HR=1.16; 95% CI 0.98 to 1.37).66
In summary, no conclusive evidence for an association 
between intakes of fruit, vegetables, protein foods or 
dairy and mortality in NHL survivors could be provided 
as evidence for each exposure and outcome was based on 
the results of one study only or on inconsistent results.
Prostate cancer
For prostate cancer, four cohort studies could be identi-
fied. Adherence to a Western diet after prostate cancer 
diagnosis was associated with increased overall mortality 
(HR=1.67; 95% CI 1.16 to 2.42) and prostate cancer-spe-
cific mortality (HR=2.53; 95% CI 1.00 to 6.42) among 
non-metastatic prostate cancer survivors in the Physi-
cian’s Health Study (PHS).67 The derived Western dietary 
patterns appeared to be driven by the consumption 
of processed meat.67 A prudent diet was investigated 
(showing overlapping characteristics with the Mediterra-
nean diet examined in the Health Professionals Follow-up 
Study (HPFS)); adherence to a prudent diet after pros-
tate cancer diagnosis was inversely associated with overall 
mortality (RR=0.64; 95% CI 0.44 to 0.93) and appeared 
to be driven by the use of oil and vinegar dressings.67 The 
HPFS reported on a Mediterranean diet and mortality 
in prostate cancer survivors after diagnosis.68 Kenfield 
et al demonstrated that postdiagnosis adherence to a 
Mediterranean diet was associated with decreased overall 
mortality (HR=0.78; 95% CI 0.67 to 0.90); no association 
was observed for prostate cancer-specific mortality and 
adherence to the Mediterranean diet.68 A prediagnosis 
high fish consumption in men who were diagnosed 
with prostate cancer while participating in the PHS was 
related to prolonged survival (HR=0.52; 95% CI 0.30 to 
0.91) according to Chavarro et al.69 Another study of Yang 
et al investigated postdiagnosis dairy intake among pros-
tate cancer survivors.70 The consumption of total dairy 
was associated with increased overall mortality (HR=1.76; 
95% CI 1.21 to 2.55). Both high-fat and low-fat dairy 
consumption contributed to this adverse association and 
overall mortality (respectively HR=1.22; 95% CI 1.08 to 
1.38 and HR=1.17; 95% CI 1.05 to 1.29).70
In summary, no conclusive evidence for an associa-
tion between a Mediterranean diet score, adherence to 
a prudent or Western diet, fish or dairy, and mortality in 
prostate cancer survivors could be provided as evidence 
for each exposure and outcome was based on the results 
of one study only.
dIsCussIOn
This systematic review summarises current scientific 
literature regarding dietary patterns/indices and foods 
from the main food groups and health outcomes among 
different groups of cancer survivors. Limited evidence 
appears to indicate that the reduction of dietary fat 
after breast cancer diagnosis could increase relapse-
free survival among breast cancer survivors, adherence 
to the HEI-2005 score after diagnosis is associated with 
decreased overall mortality, adherence to the AHEI 
diet after diagnosis is associated with decreased death 
from other causes and that adherence to a prudent diet 
after diagnosis is associated with decreased death from 
other causes among breast cancer survivors. Adherence 
to a prediagnosis Western diet is associated with death 
from other causes while postdiagnosis adherence to a 
Western diet is associated with an increased risk of overall 
mortality in breast cancer survivors. Although no conclu-
sive evidence could be provided for other survivors than 
of breast cancer, the results of available studies investi-
gating dietary patterns/indices and food in other cancer 
survivors were described in detail.
dietary patterns/indices
It could be speculated that the lack of effect in the two 
identified RCTs investigating a low-fat diet in breast 
cancer survivors is a consequence of the relatively short 
follow-up period when using mortality as the primary 
outcome.47 48 It did appear, however, that a reduction 
in dietary fat intake could increase relapse-free survival 
among these survivors.47 Nevertheless, the true benefi-
cial effect of dietary intake in this trial remains uncertain 
since increased exercise and weight loss during the inter-
vention may also have advantaged these breast cancer 
survivors.47 Adherence to a high-quality diet or a prudent 
diet and the increase in survival could be explained by 
the effects of fruit and vegetables on health in general. 
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This could also clarify the increase in mortality among 
survivors with adherence to a Western diet, as it is charac-
terised by low intakes of vegetables and fruits. It remains 
difficult, however, to disentangle the beneficial effect 
of fruit and vegetables from other foods in the diet—it 
could even be speculated that not the consumption of 
fruit and vegetables in a high-quality and prudent diet 
decrease mortality, but eating less amounts of sugars, salt 
and saturated fats could explain the associations found 
with mortality and relapse-free survival.
Besides the evidence for a potential role of a low-fat 
diet in breast cancer recurrence, most studies showed an 
association with overall mortality and death from other 
causes; not with cancer-specific mortality or cancer recur-
rence. Even if the exposures identified cannot help these 
cancer outcomes, given the survivors of the investigated 
cancers have potential for long-term survival, it is desir-
able for them to follow a diet that could help reduce other 
conditions such as cardiovascular disease and increase 
overall life expectancy. The limited number of studies 
indicates that additional long-term prospective studies 
are urgently needed to improve the strength of evidence 
on the influence of dietary pattern/indices adherence on 
cancer survival.
Foods from the main food groups
The investigated healthy dietary patterns/indices are 
characterised by foods of the main food groups. Epidemi-
ological research on fruit and vegetable intake and cancer 
risk increased rapidly over the last few decades and it has 
been suggested that people with high intakes of fruit and 
vegetables, compared with those with low intakes, have 
a reduced risk of developing cancer.71 The wide variety 
of nutrients including vitamins, minerals, phytochem-
icals and fibre in fruit and vegetables could influence 
epigenetic processes and potentially via this way improve 
cancer outcomes.72 73 However, the exact mechanisms 
of how diet can alter genetic and epigenetic changes in 
cancer cells have yet to be established. The majority of 
the identified studies found statistically non-significant 
results, based on a p value that indicates the degree to 
which the data conform to the pattern predicted by the 
test hypothesis and all the other assumptions used in the 
test. Nonetheless, the HRs<1 of two studies investigating 
prediagnosis fruit intake overall mortality,62 56 although-
statically non-significant results, could strengthen the 
evidence that adherence to a high-quality diet, char-
acterised by high intakes of fruit and vegetables, could 
decrease overall mortality in breast cancer survivors. The 
consumption of fruits could, therefore, be encouraged 
in breast cancer survivors as they are an important part 
of a high-quality diet to increase overall life expectancy. 
Studies investigating the role of fruit after diagnosis in 
cancer survivors are urgently needed.
study strengths and limitations
The strengths of this systematic review are the inclusion of 
dietary patterns/indices and whole foods, and the large 
total number of cancer survivors investigated. By exam-
ining the whole diet, the intake of nutrients in combina-
tion is considered which provides translatable real-life 
scenarios for clinical recommendations.
The limitations of this systematic review were the 
inclusion of only two RCTs, the few studies investi-
gating postdiagnosis intake, the use of FFQs to collect 
dietary information from participants in most studies, 
and the considerable heterogeneity in study design 
and participant characteristics (tumour characteristics 
(stage/grade), treatment, age, time of follow-up, 
comorbidity, differences in countries and ethnicity). 
Due to potential bias, data from observational studies 
generally provide a lower strength of evidence 
than from RCTs, even if they were well conducted. 
Conducting RCTs to investigate dietary intake in 
cancer survivors with mortality as an outcome can be 
challenging for cancers with a relatively long survival 
necessitating adherence to a diet in the long term. The 
majority of studies included in this systematic review 
investigated foods before cancer diagnosis, with only 
a few studies in the postdiagnosis setting. Information 
on food intake after diagnosis is valuable for investi-
gating the effect of dietary changes on health outcomes 
among cancer survivors—even though it is too late to 
amend lifestyle factors from before diagnosis, patients 
are more receptive to advice after diagnosis. Although 
the use of FFQs is an inexpensive approach to capture 
data from hundreds or thousands of individuals, it may 
not represent the usual foods or portion sizes chosen 
by participants, and intake data can be compromised 
when multiple foods are grouped with single listings. 
Developments in the screening, diagnosis and treat-
ment of cancers differ greatly between countries and 
therefore could influence survival. Although most 
studies are adjusted for tumour stage, age and treat-
ment, often no adjustments could be made for influen-
tial lifestyle factors including body mass index, physical 
activity and smoking. It remains a challenge to disen-
tangle the impact of diet from other lifestyle factors, 
and this should always be taken into consideration 
when interpreting study results.
COnClusIOn
To conclude, the reduction of dietary fat after breast 
cancer diagnosis could increase relapse-free survival 
among breast cancer survivors, adherence to a high-
quality diet may protect against overall mortality and 
death from other causes among breast cancer survivors, 
and adherence to a prudent diet may protect against 
death from other causes among breast cancer survi-
vors. Adherence to a Western diet before diagnosis may 
be detrimental for breast cancer survivors concerning 
death from other causes while a Western diet after 
diagnosis may increase overall mortality among these 
survivors. Additional large and well-conducted studies, 
preferably RCTs, are needed to clarify whether dietary 
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patterns/indices and food intake could influence 
health outcomes in other cancer survivors.
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